Two Sigma Investments, LP Navidea Biopharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.72 - $1.2 $24,096 - $40,160	-33,467 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.0 - $1.82 $34,312 - $62,447	-34,312 Reduced 50.62%	33,467 $33,000
Q3 2021 Nov 15, 2021	SELL	$1.53 - $1.85 $54,379 - $65,752	-35,542 Reduced 34.4%	67,779 $119,000
Q2 2021 Aug 16, 2021	SELL	$1.55 - $2.15 $64,052 - $88,846	-41,324 Reduced 28.57%	103,321 $189,000
Q1 2021 May 17, 2021	BUY	$1.99 - $2.9 $84,965 - $123,818	42,696 Added 41.88%	144,645 $292,000
Q4 2020 Feb 16, 2021	BUY	$1.88 - $2.84 $69,296 - $104,682	36,860 Added 56.63%	101,949 $219,000
Q3 2020 Nov 16, 2020	SELL	$2.69 - $4.95 $59,882 - $110,191	-22,261 Reduced 25.48%	65,089 $176,000
Q2 2020 Aug 14, 2020	BUY	$0.7 - $4.16 $61,144 - $363,376	87,350 New	87,350 $344,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.